About Ketimine reductase mu-crystallin
Ketimine reductase mu-crystallin (CRYM) is a protein
from Homo sapiens identified by UniProt accession
Q14894, 314 residues long.
MolForge cross-references it against 0 known binders and
80 disease associations.
Target properties
| Protein name | Ketimine reductase mu-crystallin |
| UniProt accession | Q14894 |
| Gene | CRYM |
| Organism | Homo sapiens |
| Length | 314 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (80)
Diseases linked to this target (Open Targets).
- autosomal dominant nonsyndromic hearing loss 40 · score 0.63
- autosomal dominant nonsyndromic hearing loss · score 0.54
- glioblastoma multiforme · score 0.05
- central nervous system cancer · score 0.04
- cancer · score 0.03
- astrocytoma · score 0.03
- lung carcinoma · score 0.02
- Huntington disease · score 0.02
- esophageal squamous cell carcinoma · score 0.02
- atypical teratoid rhabdoid tumor · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14894-F1 | alphafold | PREDICTED | 96.04 | — |
Amino-acid sequence (314 residues)
MSRVPAFLSA AEVEEHLRSS SLLIPPLETA LANFSSGPEG GVMQPVRTVV PVTKHRGYLG VMPAYSAAED ALTTKLVTFY EDRGITSVVP SHQATVLLFE PSNGTLLAVM DGNVITAKRT AAVSAIATKF LKPPSSEVLC ILGAGVQAYS HYEIFTEQFS FKEVRIWNRT KENAEKFADT VQGEVRVCSS VQEAVAGADV IITVTLATEP ILFGEWVKPG AHINAVGASR PDWRELDDEL MKEAVLYVDS QEAALKESGD VLLSGAEIFA ELGEVIKGVK PAHCEKTTVF KSLGMAVEDT VAAKLIYDSW SSGK
Explore Ketimine reductase mu-crystallin with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets